Related references
Note: Only part of the references are listed.CT in the Differentiation of Gliomas from Brain Metastases: The Radiomics Analysis of the Peritumoral Zone
Lucian Marginean et al.
BRAIN SCIENCES (2022)
Fully automated hybrid approach to predict the IDH mutation status of gliomas via deep learning and radiomics
Yoon Seong Choi et al.
NEURO-ONCOLOGY (2021)
Noninvasive Determination of IDH and 1p19q Status of Lower-grade Gliomas Using MRI Radiomics: A Systematic Review
A. P. Bhandari et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
Relative oxygen extraction fraction (rOEF) MR imaging reveals higher hypoxia in human epidermal growth factor receptor (EGFR) amplified compared with non-amplified gliomas
Talia C. Oughourlian et al.
NEURORADIOLOGY (2021)
Diffusion and perfusion MRI may predict EGFR amplification and the TERT promoter mutation status of IDH-wildtype lower-grade gliomas
Yae Won Park et al.
EUROPEAN RADIOLOGY (2020)
Human IDH mutant 1p/19q co-deleted gliomas have low tumor acidity as evidenced by molecular MRI and PET: a retrospective study
Jingwen Yao et al.
SCIENTIFIC REPORTS (2020)
Differentiating High-Grade Gliomas from Brain Metastases at Magnetic Resonance: The Role of Texture Analysis of the Peritumoral Zone
Csaba Csutak et al.
BRAIN SCIENCES (2020)
Frequent Diagnostic Under-Grading in Isocitrate Dehydrogenase Wild-Type Gliomas due to Small Pathological Tissue Samples
Marielena Gutt-Will et al.
NEUROSURGERY (2019)
Relaxation-compensated amide proton transfer (APT) MRI signal intensity is associated with survival and progression in high-grade glioma patients
Daniel Paech et al.
EUROPEAN RADIOLOGY (2019)
pH-weighted amine chemical exchange saturation transfer echoplanar imaging (CEST-EPI) as a potential early biomarker for bevacizumab failure in recurrent glioblastoma
Jingwen Yao et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Metabolic characterization of human IDH mutant and wild type gliomas using simultaneous pH- and oxygen-sensitive molecular MRI
Jingwen Yao et al.
NEURO-ONCOLOGY (2019)
Machine Learning-Based Radiomics for Molecular Subtyping of Gliomas
Chia-Feng Lu et al.
CLINICAL CANCER RESEARCH (2018)
Simultaneous pH-sensitive and oxygen-sensitive MRI of human gliomas at 3 T using multi-echo amine proton chemical exchange saturation transfer spin-and-gradient echo echo-planar imaging (CEST-SAGE-EPI)
Robert J. Harris et al.
MAGNETIC RESONANCE IN MEDICINE (2018)
Predicting IDH mutation status in grade II gliomas using amide proton transfer-weighted (APTw) MRI
Shanshan Jiang et al.
MAGNETIC RESONANCE IN MEDICINE (2017)
Hypoxia in the glioblastoma microenvironment: shaping the phenotype of cancer stem-like cells
Nicole Colwell et al.
NEURO-ONCOLOGY (2017)
In silico gene expression analysis reveals glycolysis and acetate anaplerosis in IDH1 wild-type glioma and lactate and glutamate anaplerosis in IDH1-mutated glioma
Mohammed Khurshed et al.
ONCOTARGET (2017)
The Role of Hypoxia in Glioblastoma Invasion
Ana Rita Monteiro et al.
CELLS (2017)
T2-FLAIR Mismatch, an Imaging Biomarker for IDH and 1p/19q Status in Lower- grade Gliomas: A TCGA/TCIA Project
Sohil H. Patel et al.
CLINICAL CANCER RESEARCH (2017)
Tumour acidosis: from the passenger to the driver's seat
Cyril Corbet et al.
NATURE REVIEWS CANCER (2017)
Magnetic Resonance Spectroscopy for Detection of 2-Hydroxyglutarate as a Biomarker for IDH Mutation in Gliomas
Thomas Leather et al.
METABOLITES (2017)
Bidirectional Contrast agent leakage correction of dynamic susceptibility contrast (DSC)-MRI improves cerebral blood volume estimation and survival prediction in recurrent glioblastoma treated with bevacizumab
Kevin Leu et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2016)
Simulation, phantom validation, and clinical evaluation of fast pH-weighted molecular imaging using amine chemical exchange saturation transfer echo planar imaging (CEST-EPI) in glioma at 3T
Robert J. Harris et al.
NMR IN BIOMEDICINE (2016)
IDH mutation status is associated with a distinct hypoxia/angiogenesis transcriptome signature which is non-invasively predictable with rCBV imaging in human glioma
Philipp Kickingereder et al.
SCIENTIFIC REPORTS (2015)
Evaluation of the microenvironmental heterogeneity in high-grade gliomas with IDH1/2 gene mutation using histogram analysis of diffusion-weighted imaging and dynamic-susceptibility contrast perfusion imaging
Seunghyun Lee et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Pretreatment Dynamic Susceptibility Contrast MRI Perfusion in Glioblastoma: Prediction of EGFR Gene Amplification
A. Gupta et al.
CLINICAL NEURORADIOLOGY (2015)
Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials
Benjamin M. Ellingson et al.
NEURO-ONCOLOGY (2015)
Lactate dehydrogenase A silencing in IDH mutant gliomas
Charles Chesnelong et al.
NEURO-ONCOLOGY (2014)
Recurrent Glioblastoma Treated with Bevacizumab: Contrast-enhanced T1-weighted Subtraction Maps Improve Tumor Delineation and Aid Prediction of Survival in a Multicenter Clinical Trial
Benjamin M. Ellingson et al.
RADIOLOGY (2014)
Potential Role of Preoperative Conventional MRI Including Diffusion Measurements in Assessing Epidermal Growth Factor Receptor Gene Amplification Status in Patients with Glioblastoma
R. J. Young et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2013)
MR-based hypoxia measures in human glioma
Vivien Toth et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Involvement of tumor acidification in brain cancer pathophysiology
Avinash Honasoge et al.
FRONTIERS IN PHYSIOLOGY (2013)
DNA hypermethylation and 1p Loss silence NHE-1 in oligodendroglioma
Michael D. Blough et al.
ANNALS OF NEUROLOGY (2012)
Combined spin- and gradient-echo perfusion-weighted imaging
Heiko Schmiedeskamp et al.
MAGNETIC RESONANCE IN MEDICINE (2012)
Evidence for Sequenced Molecular Evolution of IDH1 Mutant Glioblastoma From a Distinct Cell of Origin
Albert Lai et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Magnetic resonance perfusion-weighted imaging defines angiogenic subtypes of oligodendroglioma according to 1p19q and EGFR status
Gurpreet S. Kapoor et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Regional hypoxia in glioblastoma multiforme quantified with [18F] fluoromisonidazole positron emission tomography before radiotherapy:: Correlation with time to progression and survival
Alexander M. Spence et al.
CLINICAL CANCER RESEARCH (2008)
Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer
Aleksandra Franovic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Association between fluorine-18-labeled fluorodeoxyglucose uptake and 1p and 19q loss of heterozygosity in World Health Organization Grade II gliomas
Florian Stockhammer et al.
JOURNAL OF NEUROSURGERY (2007)
Epidermal growth factor receptor-mediated signal transduction in the development and therapy of gliomas
M. Kelly Nicholas et al.
CLINICAL CANCER RESEARCH (2006)
Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastoma
M Aghi et al.
CLINICAL CANCER RESEARCH (2005)
Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis
B Kaur et al.
NEURO-ONCOLOGY (2005)
Share Paper
